LONDON & FT. LAUDERDALE, Fla. — Trividia Health UK Limited has announced the launch of its TRUEplus 5-Bevel Pen Needles in the United Kingdom, marking the product’s first expansion beyond the U.S. market. The new line is designed to enhance patient comfort during insulin injections while offering a more affordable option for people managing diabetes.
The TRUEplus 5-Bevel Pen Needles are engineered for comfort and ease of use, featuring a unique 5-bevel design intended to minimize injection pain and improve overall patient experience. The needles are available in various sizes to suit individual patient needs, including 31-gauge options in 5mm, 6mm, and 8mm lengths, as well as a 32-gauge 4mm option.
“Providing accessibility to a range of products for patients to confidently manage their diabetes is a priority for us at Trividia Health,” said Jonathan Chapman, President and CEO of Trividia Health. “With the TRUEplus 5-Bevel Pen Needles now registered in the UK, healthcare providers can offer high-quality, low-cost options for insulin delivery.”
Notably, the TRUEplus 5-Bevel Pen Needles are now the lowest-priced 5-bevel pen needles available by prescription in the UK. Many patients currently use older, less comfortable 3-bevel needles at similar or higher costs.
The product is already widely available in the U.S. under the TRUEplus brand and through major national pharmacy chains. Its entry into the UK market represents a significant step in Trividia’s international expansion and commitment to improving diabetes care globally.
